These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 267379

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Peripheral neuropathy in osteosclerotic myeloma: clinical and electrodiagnostic improvement with chemotherapy.
    Donofrio PD, Albers JW, Greenberg HS, Mitchell BS.
    Muscle Nerve; 1984 Feb; 7(2):137-41. PubMed ID: 6325905
    [Abstract] [Full Text] [Related]

  • 5. Peptichemio in multiple myeloma. (Preliminary results).
    Cavo M, Gobbi M, Tura S.
    Haematologica; 1981 Apr; 66(2):208-15. PubMed ID: 6791997
    [No Abstract] [Full Text] [Related]

  • 6. Remission maintenance therapy for multiple myeloma.
    Arch Intern Med; 1975 Jan; 135(1):147-52. PubMed ID: 1111463
    [Abstract] [Full Text] [Related]

  • 7. [Recent progress in chemotherapy of multiple myeloma].
    Tortarolo M, Cantore N, Russolillo S, Castaldo C, Buonanno G.
    Recenti Prog Med; 1978 Jul; 65(1):44-68. PubMed ID: 370935
    [No Abstract] [Full Text] [Related]

  • 8. Regression of amyloidosis in multiple myeloma.
    Mehta AD.
    Br J Clin Pract; 1978 Dec; 32(12):358-9, 61. PubMed ID: 737115
    [No Abstract] [Full Text] [Related]

  • 9. Prognostic factors and survival in multiple myeloma. Analysis of 91 cases treated by melphalan and prednisone.
    Gobbi M, Cavo M, Savelli G, Baccarani M, Tura S.
    Haematologica; 1980 Aug; 65(4):437-45. PubMed ID: 6774915
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Pleural effusion as a first sign of Ig D lambda multiple myeloma].
    Maachi M, Fellahi S, Diop ME, Francois T, Capeau J, Bastard JP.
    Ann Med Interne (Paris); 2003 Feb; 154(1):70-2. PubMed ID: 12746663
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Current management of multiple myeloma.
    Korst DR.
    Wis Med J; 1968 Nov; 67(11):566-8. PubMed ID: 5747569
    [No Abstract] [Full Text] [Related]

  • 16. [Intermittent low dose melphalan and prednisone in multiple myeloma].
    Yalon M, Levo Y, Many A, Ramot B.
    Harefuah; 1977 Apr 01; 92(7):296-8. PubMed ID: 863310
    [No Abstract] [Full Text] [Related]

  • 17. Melphalan and its role in the management of patients with multiple myeloma.
    Falco P, Bringhen S, Avonto I, Gay F, Morabito F, Boccadoro M, Palumbo A.
    Expert Rev Anticancer Ther; 2007 Jul 01; 7(7):945-57. PubMed ID: 17627453
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Prognosis and therapy of multiple myeloma].
    Sonntag RW.
    Schweiz Med Wochenschr; 1978 Aug 12; 108(32):1247-51. PubMed ID: 675217
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.